D-Allulose: A Review of In Vivo Metabolism, Catalytic Mechanism, Engineered Strain Construction, and Biosynthesis

Opening

Allulose is not a hypothetical sweetener. It is already in beverages, baked goods, ice cream, and yogurt. The question for formulators is how well you understand it. This review, published in Frontiers in Bioengineering and Biotechnology (DOI: 10.3389/fbioe.2020.00026), pulls together the metabolic, enzymatic, and production-side science in one place. That makes it a practical reference, not just an academic exercise.

Background

D-allulose is a low-energy monosaccharide. It delivers about 70% of the sweetness of sucrose. Its energy value is 0.2 kcal/g. That translates to a 95% calorie reduction compared with sucrose. The FDA has confirmed it as GRAS for food use. Those numbers alone explain the commercial interest.

The review also points to physiological effects. D-allulose may help improve insulin resistance, support blood glucose control, and reduce abdominal fat accumulation. For a sweetener, that is a strong profile. It offers function, not just sweetness.

What the study did

The review systematically analyzed the enzyme properties behind D-allulose. It looked at how engineered microbial strains can be built for efficient biosynthesis. It also covered green cyclic production processes that aim to reduce waste and improve sustainability.

This is not a single lab study. It is a map of the field. For ingredient buyers and formulators, that matters. You need to know where the ingredient comes from and where the technology is heading.

Key findings

The review makes several points clear.

• D-allulose is sweet, but not as sweet as sucrose. At about 70% sweetness, you may need to blend or adjust dosage.
• The calorie load is very low. At 0.2 kcal/g, it gives you a meaningful calorie reduction.
• The physiological data supports uses in products aimed at blood sugar management and weight control.
• Production science is advancing. Enzyme catalysts and engineered microbial strains are central to commercial scale.
• Green cyclic production processes are part of the future, so supply chains can become cleaner.

Attribute	D-Allulose	Sucrose
Sweetness	~70% of sucrose	Baseline
Energy	0.2 kcal/g	Reference (allulose cuts calories by 95%)
FDA status	GRAS	Standard food ingredient
Documented applications	Beverages, baked goods, ice cream, yogurt	—
Reported metabolic effects	Improved insulin sensitivity, blood glucose control, reduced abdominal fat	—

The table does not show a complete nutritional comparison. It shows what the review actually covers. Use it as a starting point for your own evaluation.

What it means for manufacturers

You can formulate lower-calorie products without abandoning sugar-like sweetness. Allulose works in categories where texture and mouthfeel matter, like ice cream and yogurt. The review names these applications directly.

You should also consider the metabolic angle. If your brand targets blood sugar control or weight management, D-allulose gives you evidence to build on. The review links it to improved insulin resistance, better glucose control, and lower abdominal fat accumulation. Those are consumer-relevant benefits.

Supply matters too. The review details engineered strains and green cyclic processes. That tells you the production side is moving toward efficiency. For buyers, this means more viable suppliers and better cost trajectories over time.

FAQ

Does allulose really deliver a 95% calorie reduction?

Yes. The review states that D-allulose is 0.2 kcal/g and that this is a 95% reduction compared with sucrose. That is a large drop for an ingredient with 70% of sugar's sweetness.

What health effects should formulators know about?

The review reports three main areas: improved insulin resistance, blood glucose control, and reduced abdominal fat accumulation. These are especially relevant for low-sugar and metabolic health positioning.

How is allulose produced?

The review focuses on enzyme properties, engineered strain construction, and green cyclic production processes. That points to a biocatalytic route using optimized microbial strains.

Closing

The science behind D-allulose is maturing. This review gives you the metabolic context, the catalytic details, and the production roadmap. For formulators, that means fewer unknowns. For buyers, it means a clearer path to reliable supply. The ingredient is already GRAS. It is already in products. Now you have the evidence to move forward.